JSPR
Jasper TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
JSPR vs peer average
95/100
JSPR vs. peer average (A vs. D)
Grade spread
A 2 · D 4 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
VYNE is the first available peer comparator.
Small-cap life sciences peer that helps frame how capital-market pressure and sparse coverage can dominate near-term price discovery.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
JSPR
Jasper Therapeutics
VYNE
VYNE Therapeutics
Grade
A
F
Momentum
61
36
Value
58
41
Sentiment
68
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs VYNE
JSPR / VYNE
Grade Position
Above peers
JSPR vs. peer average (A vs. D)
95/100
Momentum
61
JSPRValue
58
JSPRSentiment
68
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs JSPR
VYNE is the first peer returned for this comparison set.